Surgical management of fibrous dysplasia: recurrence and functional outcomes based on MSTS and TESS evaluation
European Journal of Orthopaedic Surgery & Traumatology · 05.11.2026 · 37 (1)
DOI: 10.1007/s00590-026-05017-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Orthopaedic Surgery & Traumatology, online erschienen am 05.11.2026. Verfasst von Aras Pervane und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics and Traumatology, Ankara Bilkent City Hospital, Ankara, Turkey. araspervane92@gmail.com. Hauptthemen laut MEDLINE: Fibrous Dysplasia of Bone. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVE: Fibrous dysplasia (FD) is a benign bone disorder with variable clinical presentation and controversial management strategies. This study aimed to evaluate the clinical characteristics, surgical outcomes, recurrence rates, and functional results of patients with FD using Musculoskeletal Tumor Society (MSTS) and Toronto Extremity Salvage Score (TESS) systems. METHODS: A retrospective analysis was conducted on 62 patients who underwent surgical treatment for FD between 2000 and 2022 at a tertiary referral center. Demographic data, clinical characteristics, presenting complaints, surgical methods, graft use, and recurrence were evaluated. Functional outcomes were assessed using MSTS and TESS scores. Statistical analyses were performed to determine factors affecting recurrence and functional outcomes. RESULTS: The mean age was 28.77 ± 14.72 years. Pain was the most common presenting complaint (50.0%). The proximal femur was the most frequently affected site (33.9%), and most lesions involved the lower extremity (82.3%). Recurrence occurred in 13 of 62 cases (21.0%) and was associated with presenting complaint (p = 0.001), being more common in patients presenting with pain. No significant association was found between recurrence and surgical method or graft use (p > 0.05). Mean MSTS and TESS scores were 90.56 ± 11.55 and 88.49 ± 9.86, respectively. Exploratory comparisons did not identify significant differences by surgical method or graft use. CONCLUSION: Surgical treatment of FD provides favorable functional outcomes with low complication rates. Clinical presentation and disease type significantly influence functional results and recurrence, whereas surgical technique and grafting do not appear to affect outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics and Traumatology, Ankara Bilkent City Hospital, Ankara, Turkey. araspervane92@gmail.com.
- Keçiören Training and Research Hospital, Ankara, Turkey.
- Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
- Department of Orthopedics and Traumatology, Ankara Bilkent City Hospital, Ankara, Turkey.
- Ankara Yildirim Beyazit University, Ankara Türkiye, Ankara, Turkey.
ORCID-Profile: Aras Pervane, İsmail Burak Atalay, İbrahim Kaya
Zitieren
APA
Pervane, A., Gökşen, T. C., Atalay, İ. B., Kaya, İ., Emir, M. M., Arıcan, N., Atalay, M., & Bingol, I. (2026). Surgical management of fibrous dysplasia: recurrence and functional outcomes based on MSTS and TESS evaluation. European Journal of Orthopaedic Surgery & Traumatology, 37(1). https://doi.org/10.1007/s00590-026-05017-0
Vancouver
Pervane A, Gökşen TC, Atalay İB, Kaya İ, Emir MM, Arıcan N, et al. Surgical management of fibrous dysplasia: recurrence and functional outcomes based on MSTS and TESS evaluation. European Journal of Orthopaedic Surgery & Traumatology. 2026;37(1). doi:10.1007/s00590-026-05017-0
BibTeX
@article{Pervane2026,
author = {Pervane, Aras and Gökşen, Tekin Can and Atalay, İsmail Burak and Kaya, İbrahim and Emir, Mehmet Musa and Arıcan, Nevzat and Atalay, Melih and Bingol, Izzet},
title = {Surgical management of fibrous dysplasia: recurrence and functional outcomes based on MSTS and TESS evaluation},
journal = {European Journal of Orthopaedic Surgery & Traumatology},
year = {2026},
volume = {37},
number = {1},
doi = {10.1007/s00590-026-05017-0}
}
EUVIMED